Papp K, Reich K, Leonardi CL, Kircik L, Chimenti S, Langley RG, Hu C, Stevens RM, Day RM, Gordon KB, Korman NJ, Griffiths CE (2015) Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
Several common skin whitening treatments are available, each working differently and having varying effectiveness, potential risks, and side effects
Insights into GLP-1 and GIP actions emerging from vildagliptin mechanism studies in man
We know that they both really do increase GH, and this helps your cells get what they need to function properly, repair themselves, and create new, healthy cells